Annabelle Garnier
Overview
Explore the profile of Annabelle Garnier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tessier E, Cheutin L, Garnier A, Vigne C, Tournier J, Rougeaux C
Microorganisms
. 2024 Feb;
12(2).
PMID: 38399712
Anthrax toxins are critical virulence factors of and strains that cause anthrax-like disease, composed of a common binding factor, the protective antigen (PA), and two enzymatic proteins, lethal factor (LF)...
2.
Le Hir A, Durand G, Boucraut J, Garnier A, Mura M, Diamantis S, et al.
J Travel Med
. 2023 Dec;
31(2).
PMID: 38123499
Background: Immunization against the Yellow fever virus (YFV) with the 17D live-attenuated vaccine is the most effective way to prevent the disease. However, unexpected severe adverse events can occur. They...
3.
Riviere F, Burger J, Lefevre F, Garnier A, Vigne C, Tournier J, et al.
Front Immunol
. 2023 Aug;
14:1241323.
PMID: 37649477
Introduction: Inflammatory lesions after Influenza A viruses (IAV) are potential therapeutic target for which better understanding of post-infection immune mechanisms is required. Most studies to evaluate innate immune reactions induced...
4.
Denis J, Garnier A, Cheutin L, Ferrier A, Timera H, Jarjaval F, et al.
Front Immunol
. 2023 Mar;
14:1140714.
PMID: 36969158
Introduction: Current approved COVID-19 vaccines, notably mRNA and adenoviral vectored technologies, still fail to fully protect against infection and transmission of various SARS-CoV-2 variants. The mucosal immunity at the upper...
5.
Verguet N, Mondange L, Nolent F, Depeille A, Garnier A, Neulat-Ripoll F, et al.
Res Microbiol
. 2023 Mar;
174(6):104053.
PMID: 36925026
Contamination with microorganisms occurs in laboratories but is also of high concern in the context of bioterrorism. Decontamination is a cornerstone that promotes good laboratory practices and occupational health and...
6.
Billon-Denis E, Ferrier-Rembert A, Garnier A, Cheutin L, Vigne C, Tessier E, et al.
Infection
. 2021 Jan;
49(4):781-783.
PMID: 33387262
Background: We report here the case of two coworkers infected by the same SARS-CoV-2 strain, presenting two different immunological outcomes. Case: One patient presented a strong IgG anti-receptor-binding domain immune...
7.
Denis J, Attoumani S, Gravier P, Tenebray B, Garnier A, Briolant S, et al.
PLoS Negl Trop Dis
. 2019 Sep;
13(9):e0007747.
PMID: 31539394
Background: Zika virus (ZIKV) and Dengue virus (DENV) are often co-endemic. The high protein-sequence homology of flaviviruses renders IgG induced by and directed against them highly cross-reactive against their antigen(s),...
8.
De Vleeschauwer A, Zhou X, Lefebvre D, Garnier A, Watier F, Pignon C, et al.
Vaccine
. 2018 Mar;
36(16):2193-2198.
PMID: 29544690
Vaccination is a key element in the control of foot-and-mouth disease (FMD). The majority of the antigenic sites that induce protective immune responses are localized on the FMD virus (FMDV)...
9.
Beck C, Despres P, Paulous S, Vanhomwegen J, Lowenski S, Nowotny N, et al.
Biomed Res Int
. 2015 Oct;
2015:678084.
PMID: 26457301
West Nile virus (WNV), Japanese encephalitis virus (JEV), and tick-borne encephalitis virus (TBEV) are flaviviruses responsible for severe neuroinvasive infections in humans and horses. The confirmation of flavivirus infections is...